| Symbol | OVIT |
|---|---|
| Name | ONCOVISTA INNOVATIVE THERAPIES, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 78245 United States TX 14785 Omicron Drive Suite 104 |
| Telephone | (210) 677-6000 |
| Fax | — |
| — | |
| Website | http://www.oncovista.com |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | GHP Horwath PC; |
| Audit Status | AUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001094847 |
| Description | OncoVista Innovative Therapies, Inc. is a high-growth theragnostic (the fusion of therapeutic and diagnostic medicine for individual patients) company that identifies specific biomarkers in the bloodstream carried by CTCs to detect metastatic tumors. This technology allows an oncologist the unique ability to develop personalized, efficacious cancer treatments, thereby evaluating cancer therapeutic efficacy that can dramatically improve a patients chance of survival. OncoVista also produces innovative drug discovery, registration strategies and emerging technologies allowing it to bring to market less toxic and highly effective anti-cancer drugs. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: ONCOVISTA INNVTVE THERPS.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: ONCOVISTA INNVTVE THERPS.
Read more